Compass Biotechnologies Inc., a development stage biotechnology company, develops licenses for patents pertaining to the technology utilized in the prevention and treatment of hepatitis C. It focuses on the development and commercialization of generic, biosimiliar, and biobetter drugs. The company was formerly known as Cyplasin Biomedical, Ltd. and changed its name to Compass Biotechnologies Inc. in March 2011. Compass Biotechnologies Inc. was incorporated in 2004 and is based in Lake Mary, Florida.
Subscribe
Login
Join
Connect with us
